Medicare Enrolled
Dr. George Schiffman, M.D.
Pulmonary Disease · Mission Viejo, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schiffman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schiffman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schiffman
Dr. George Schiffman is a pulmonary disease specialist in Mission Viejo, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schiffman performed 926 Medicare services across 650 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schiffman received a total of $4,072 from 41 pharmaceutical and/or device companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schiffman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 39% volume in CA
$4,072 industry payments
Medicare Practice Summary
Medicare Utilization ↗926
Medicare services
Top 39% in CA for pulmonary disease
650
Unique beneficiaries
$134
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~46 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
229 | $173 | $743 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
157 | $99 | $266 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
141 | $105 | $345 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
69 | $66 | $185 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
45 | $49 | $165 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
45 | $529 | $1,823 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
44 | $47 | $153 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $69 | $245 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
35 | $73 | $472 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
34 | $32 | $111 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $133 | $485 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $143 | $447 |
| New patient office visit, complex (60-74 min) | 17 | $183 | $591 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
14 | $24 | $75 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
12 | $474 | $1,757 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,072
Total received (2018-2024)
Avg $679/year across 6 years
Top 30% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
190
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,742 (91.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$330 (8.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$637
2023
$681
2022
$194
2020
$177
2019
$1,014
2018
$1,370
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
HARMONY BIOSCIENCES LLC
$113
Inari Medical, Inc.
$87
Actelion Pharmaceuticals US, Inc.
$77
Mylan Specialty L.P.
$59
ABBVIE INC.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
PFIZER INC.
$42
GENZYME CORPORATION
$38
Takeda Pharmaceuticals U.S.A., Inc.
$33
GlaxoSmithKline, LLC.
$28
Avadel CNS Pharmaceuticals, LLC
$23
Amgen Inc.
$22
Inspire Medical Systems, Inc.
$18
Top 3 companies account for 43.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$795
Boehringer Ingelheim Pharmaceuticals, Inc.
$626
Astellas Pharma US Inc
$330
Actelion Pharmaceuticals US, Inc.
$201
Sunovion Pharmaceuticals Inc.
$194
Harmony Biosciences LLC
$168
Genentech USA, Inc.
$156
Mylan Specialty L.P.
$142
GENZYME CORPORATION
$118
HARMONY BIOSCIENCES LLC
$113
Janssen Pharmaceuticals, Inc
$102
AstraZeneca Pharmaceuticals LP
$87
Inari Medical, Inc.
$87
Gilead Sciences, Inc.
$70
Allergan Inc.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$66
Baxter Healthcare
$63
Shire North American Group Inc
$63
PFIZER INC.
$60
Philips Electronics North America Corporation
$56
ABBVIE INC.
$52
United Therapeutics Corporation
$44
JAZZ PHARMACEUTICALS INC.
$32
CMP Pharma, Inc.
$32
Circassia Pharmaceuticals Inc
$31
Fisher & Paykel Healthcare Inc
$31
Insmed, Inc.
$28
Avadel CNS Pharmaceuticals, LLC
$23
PORTOLA PHARMACEUTICALS, INC.
$22
Melinta Therapeutics, Inc.
$22
Grifols USA, LLC
$22
Amgen Inc.
$22
Alexion Pharmaceuticals, Inc.
$22
Merck Sharp & Dohme Corporation
$19
Itamar Medical Inc
$19
Inspire Medical Systems, Inc.
$18
Pulmonx Corporation
$18
Advanced Respiratory, Inc
$16
E.R. Squibb & Sons, L.L.C.
$14
Bayer HealthCare Pharmaceuticals Inc.
$11
bioMerieux
$10
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ANDEXXA · ANORO · ASMANEX · AVYCAZ · Adempas · Arikayce · BREO · BROVANA · Baxdela · CRESEMBA · CUVITRU · DALVANCE · DUPIXENT · DreamStat Cpap Auto · ELIQUIS · Esbriet · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · INSPIRE · LONHALA MAGNAIR · LUMRYZ · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PREVNAR 20 · Perforomist · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · S · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Tadliq · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · VIDAS BRAHMS PCT · WAKIX · Wakix · WatchPATONE · XARELTO · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
95
Per 100K population
3.0
County median income
$113,702
Nearest hospital
PROVIDENCE MISSION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schiffman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schiffman experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Schiffman performed 229 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schiffman receive payments from pharmaceutical companies?
Yes. Dr. Schiffman received a total of $4,072 from 41 companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schiffman's costs compare to other pulmonary diseases in Mission Viejo?
Dr. Schiffman's average Medicare payment per service is $134. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schiffman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Mission Viejo
Browse pulmonary diseases in Mission Viejo ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology